Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1800 1
1802 1
1815 1
1828 1
1841 1
1843 1
1844 1
1855 2
1859 5
1860 2
1867 3
1868 2
1869 1
1870 1
1871 2
1874 1
1876 1
1877 1
1878 2
1879 3
1880 3
1881 1
1883 2
1884 1
1885 2
1886 2
1888 1
1889 1
1890 1
1891 1
1896 2
1897 3
1898 1
1901 2
1902 1
1908 1
1912 2
1914 2
1915 1
1917 1
1918 3
1920 4
1921 2
1922 5
1923 1
1925 2
1926 1
1927 2
1928 3
1930 3
1931 2
1932 3
1933 3
1934 3
1935 2
1936 1
1937 4
1938 4
1939 8
1941 4
1942 5
1943 1
1944 6
1945 4
1946 22
1947 33
1948 29
1949 34
1950 37
1951 31
1952 36
1953 31
1954 17
1955 41
1956 46
1957 42
1958 37
1959 42
1960 42
1961 24
1962 47
1963 60
1964 72
1965 66
1966 85
1967 84
1968 107
1969 93
1970 91
1971 105
1972 117
1973 87
1974 94
1975 135
1976 142
1977 148
1978 145
1979 161
1980 120
1981 148
1982 147
1983 175
1984 201
1985 183
1986 180
1987 185
1988 208
1989 216
1990 248
1991 236
1992 261
1993 243
1994 245
1995 233
1996 270
1997 249
1998 275
1999 249
2000 257
2001 252
2002 314
2003 299
2004 335
2005 375
2006 386
2007 425
2008 477
2009 475
2010 605
2011 569
2012 639
2013 707
2014 782
2015 709
2016 832
2017 726
2018 769
2019 835
2020 939
2021 1004
2022 939
2023 236
Text availability
Article attribute
Article type
Publication date

Search Results

19,014 results
Results by year
Filters applied: . Clear all
Page 1
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Bottomly D, Long N, Schultz AR, Kurtz SE, Tognon CE, Johnson K, Abel M, Agarwal A, Avaylon S, Benton E, Blucher A, Borate U, Braun TP, Brown J, Bryant J, Burke R, Carlos A, Chang BH, Cho HJ, Christy S, Coblentz C, Cohen AM, d'Almeida A, Cook R, Danilov A, Dao KT, Degnin M, Dibb J, Eide CA, English I, Hagler S, Harrelson H, Henson R, Ho H, Joshi SK, Junio B, Kaempf A, Kosaka Y, Laderas T, Lawhead M, Lee H, Leonard JT, Lin C, Lind EF, Liu SQ, Lo P, Loriaux MM, Luty S, Maxson JE, Macey T, Martinez J, Minnier J, Monteblanco A, Mori M, Morrow Q, Nelson D, Ramsdill J, Rofelty A, Rogers A, Romine KA, Ryabinin P, Saultz JN, Sampson DA, Savage SL, Schuff R, Searles R, Smith RL, Spurgeon SE, Sweeney T, Swords RT, Thapa A, Thiel-Klare K, Traer E, Wagner J, Wilmot B, Wolf J, Wu G, Yates A, Zhang H, Cogle CR, Collins RH, Deininger MW, Hourigan CS, Jordan CT, Lin TL, Martinez ME, Pallapati RR, Pollyea DA, Pomicter AD, Watts JM, Weir SJ, Druker BJ, McWeeney SK, Tyner JW. Bottomly D, et al. Among authors: brown j. Cancer Cell. 2022 Aug 8;40(8):850-864.e9. doi: 10.1016/j.ccell.2022.07.002. Epub 2022 Jul 21. Cancer Cell. 2022. PMID: 35868306 Free article.
Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, Stevenson KE, Tausch E, Delgado J, Barbera-Mourelle A, Taylor-Weiner A, Bousquets-Muñoz P, Diaz-Navarro A, Dunford A, Anand S, Kretzmer H, Gutierrez-Abril J, López-Tamargo S, Fernandes SM, Sun C, Sivina M, Rassenti LZ, Schneider C, Li S, Parida L, Meissner A, Aguet F, Burger JA, Wiestner A, Kipps TJ, Brown JR, Hallek M, Stewart C, Neuberg DS, Martín-Subero JI, Puente XS, Stilgenbauer S, Wu CJ, Campo E, Getz G. Knisbacher BA, et al. Among authors: brown jr. Nat Genet. 2022 Nov;54(11):1664-1674. doi: 10.1038/s41588-022-01140-w. Epub 2022 Aug 4. Nat Genet. 2022. PMID: 35927489
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, O'Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. N Engl J Med. 2023 Jan 26;388(4):319-332. doi: 10.1056/NEJMoa2211582. Epub 2022 Dec 13. N Engl J Med. 2023. PMID: 36511784 Clinical Trial.
Streptococcus pneumoniae interactions with the complement system.
Gil E, Noursadeghi M, Brown JS. Gil E, et al. Among authors: brown js. Front Cell Infect Microbiol. 2022 Jul 28;12:929483. doi: 10.3389/fcimb.2022.929483. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35967850 Free PMC article. Review.
Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.
Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, Tewari S, Trestan L, Alali Z, Bayik D, Lathia JD, Sangwan N, Bazeley P, Joehlin-Price AS, Wang Z, Dutta S, Dwidar M, Hajjar A, Ahern PP, Claesen J, Rose P, Vargas R, Brown JM, Michener CM, Reizes O. Chambers LM, et al. Among authors: brown jm. Cancer Res. 2022 Dec 16;82(24):4654-4669. doi: 10.1158/0008-5472.CAN-22-0455. Cancer Res. 2022. PMID: 36206317
Latent Tuberculosis Infection Care.
Gaskell KM, Pillay TD, Brown J, Belton M, Mepham SO, Moore DAJ, Lipman M. Gaskell KM, et al. Among authors: brown j. Clin Infect Dis. 2022 Nov 14;75(10):1864. doi: 10.1093/cid/ciac582. Clin Infect Dis. 2022. PMID: 35869842 No abstract available.
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis.
Zheng B, Daines L, Han Q, Hurst JR, Pfeffer P, Shankar-Hari M, Elneima O, Walker S, Brown JS, Siddiqui S, Quint JK, Brightling CE, Evans RA, Wain LV, Heaney LG, Sheikh A. Zheng B, et al. Among authors: brown js. Eur Respir Rev. 2022 Nov 2;31(166):220071. doi: 10.1183/16000617.0071-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36323418 Free PMC article. Review.
Editorial: Mechanisms guarding the genome.
Brown JAL, Bourke E, Hancock WW, Richard DJ. Brown JAL, et al. Front Cell Dev Biol. 2022 Aug 15;10:974545. doi: 10.3389/fcell.2022.974545. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36046336 Free PMC article. No abstract available.
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
Hillmen P, Eichhorst B, Brown JR, Lamanna N, O'Brien SM, Tam CS, Qiu L, Kazmierczak M, Zhou K, Šimkovič M, Mayer J, Gillespie-Twardy A, Shadman M, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Österborg A, Yimer HA, Salmi T, Ji M, Yecies J, Idoine A, Wu K, Huang J, Jurczak W. Hillmen P, et al. Among authors: brown jr. J Clin Oncol. 2023 Feb 10;41(5):1035-1045. doi: 10.1200/JCO.22.00510. Epub 2022 Nov 17. J Clin Oncol. 2023. PMID: 36395435 Free PMC article. Clinical Trial.
Priced out of training?
Brown J. Brown J. Med J Aust. 2022 Oct 17;217(8):434. doi: 10.5694/mja2.51723. Epub 2022 Sep 13. Med J Aust. 2022. PMID: 36100241 No abstract available.
19,014 results
You have reached the last available page of results. Please see the User Guide for more information.